Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG?

dc.contributor.authorGwee, A.en_US
dc.contributor.authorRodrigo, R.en_US
dc.contributor.authorCasalaz, D.en_US
dc.contributor.authorRitz, N.en_US
dc.contributor.authorCurtis, N.en_US
dc.creator.corporateauthorAustralian Medical Associationen_US
dc.creator.corporateauthorBritish Medical Associationen_US
dc.date.accessioned2014-10-29T09:40:37Zen_US
dc.date.available2014-10-29T09:40:37Zen_US
dc.date.issued2013en_US
dc.descriptionIndexed in MEDLINE; Comment in: [Gwee A et al, Med J Aust. 2014 ;200(3):149-50.]; Beard FH, Med J Aust. 2014; 200(3):149]en_US
dc.description.abstractComment on effectiveness of BCG vaccine as a preventive therapy in reducing risk of young children travelling to countries with a high prevalence of TB.en_US
dc.identifier.citationThe Medical Journal Australia. 2013; 199(5): 324-6en_US
dc.identifier.departmentPaediatricsen_US
dc.identifier.issn0025-729X (Print)en_US
dc.identifier.issn1326-5377 (Electronic)en_US
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/2241en_US
dc.publisherAustralasian Medical Publishing Coen_US
dc.titleInfants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG?en_US
dc.typeLetteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: